Chemical Structure (Combogesic 01)
Combogesic Tablet, Film Coated
Product Images NDC 72260-129
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Combogesic (NDC 72260-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aft Pharmaceuticals Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Combogesic 02)
Figure 1 (Combogesic 03)
This text provides information on Pain Intensity Difference in millimeters for different medications including ComboGesic (n=110), Ibuprofen (n=112), Acetaminophen (n=111), and Placebo (n=75). The data is likely from a study or research comparing the pain relief efficacy of these medications over time.*
Principal Display Panel (325 mg/97.5 mg Tablet Bottle Label)
The text provides information about a medication called Combogesic, a combination of acetaminophen and ibuprofen tablets. Each film-coated tablet contains 325 mg of Acetaminophen and 97.5 mg of Ibuprofen. The recommended dosage instructions ask to refer to the prescribing information for detailed dosage instructions. There are 250 film-coated tablets in the lot. It also specifies storage conditions between 20-25°C (68°F-77°F) with excursions permitted to 15°-30°C (59°-86°F). The medication guide should be provided separately to each patient, and the product is distributed by AFT Pharmaceuticals in the United States.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
